Impact of IL-22: A promising biomarker for molecular targeted drug response in PsA?
Arthritis Care & Research | Apr 22, 2022
Predicting flares post-remission and treatment withdrawal in early RA
Arthritis Care & Research | Apr 16, 2022
The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis
Arthritis Research & Therapy | Apr 09, 2022
Risk prediction models for atherosclerotic cardiovascular disease in patients with chronic kidney disease: The CRIC Study
Journal of the American Society of Nephrology | Feb 15, 2022